Announcements Trials
Browse Landscape

Phase

Phase 3 6Phase NA 3Phase 4 2Phase 2 2

Status

Completed 5Terminated 1

Sponsor Class

OTHER 6NETWORK 2

Study Type

Interventional 6

Sponsor

Cancer Type

Genitourinary 3Breast 2Other hematologic neoplasm 1Lymphoid 1

Conditions

Osteoporosis 4Prostatic Neoplasms 3Breast Neoplasms 2Bone Diseases, Metabolic 2Prostatic Hyperplasia 1Precursor Cell Lymphoblastic Leukemia-Lymphoma 1Lymphoma 1Leukemia 1

Interventions

Cisplatin 294Radiotherapy 230Fluorouracil 201Cyclophosphamide 191Capecitabine 183Docetaxel 167Gemcitabine 165Oxaliplatin 162Carboplatin 161Paclitaxel 152Leucovorin 122Drug Therapy 119Dexamethasone 119Doxorubicin 112Etoposide 99Bevacizumab 91Cytarabine 87Vincristine 83Irinotecan 81Rituximab 77Epirubicin 71Prednisone 65Radiosurgery 63Methotrexate 62Surgical Procedures, Operative 61Radiation 60Radiotherapy, Intensity-Modulated 57Neoadjuvant Therapy 53Lenalidomide 52Letrozole 51

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

6 trials
RecentStart dateEnrollment
Phase 3 × OTHER × Risedronic Acid × Clear all
NCT00452439 2020-12-28

A Study of Actonel for the Prevention of Bone Loss

M.D. Anderson Cancer Center

Phase 3 Completed
72 enrolled 8 charts
LymphoidOther hematologic neoplasm

Bone Diseases, Metabolic, Leukemia, Lymphoma, Osteoporosis, Precursor Cell Lymphoblastic Leukemia-Lymphoma

NCT00043069 2016-12-07

Calcium With or Without Estrogen and/or Risedronate in Preventing Osteoporosis in Patients With Prostate Cancer

Alliance for Clinical Trials in Oncology

Phase 3 Completed
71 enrolled
Genitourinary

Osteoporosis, Prostatic Neoplasms

NCT00054418 2016-07-13

Risedronate in Preventing Bone Loss in Premenopausal Women Receiving Chemotherapy for Primary Breast Cancer

Alliance for Clinical Trials in Oncology

Phase 3 Completed
216 enrolled
Breast

Breast Neoplasms, Osteoporosis

NCT00216060 2016-05-26

Risedronate to Prevent Skeletal Related Events in Patients With Metastatic Prostate Cancer Commencing Hormonal Therapy

Hoosier Cancer Research Network

Phase 3 Terminated
63 enrolled 19 charts
Genitourinary

Prostatic Neoplasms

NCT00859703 2013-10-31

RISAROS

Hospices Civils de Lyon

Phase 3 Completed
20 enrolled
Breast

Bone Diseases, Metabolic, Breast Neoplasms, Osteoporosis

NCT00426777 2012-02-03

Efficacy Study of Risedronate to Prevent Cancer Treatment-Induced Bone Loss in Prostate Cancer

CMX Research

Phase 3 Completed
160 enrolled
Genitourinary

Prostatic Hyperplasia, Prostatic Neoplasms

Data powered by HemOnc (CC BY 4.0) Colophon âš¡